AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21439849 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids plus α-tocopherol (920 mg EPA, 760 mg DHA, 8 mg α-tocopherol per day)
Number of subjects: 25
Study 21439849 — intervention group
Group type: COMPARATOR
Intervention: α-tocopherol supplement (100 mg/week resulting in 14.2 mg/day)
Number of subjects: 25
Study 18310524 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone or tadalafil (prophylactic treatment)
Number of subjects: 24
Study 18310524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 18310524 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study 16503545 — intervention group
Group type: EXPERIMENTAL
Intervention: Selaginella (30 g) daily in 50 ml decoction during the entire course of radiotherapy
Number of subjects: 180
Study 16503545 — intervention group
Group type: EXPERIMENTAL
Intervention: Selaginella (30 g) daily in the late course of radiotherapy
Number of subjects: 180
Study 16503545 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 180
Study 12669010 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated-fat diet
Number of subjects: 26
Study 12669010 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 26
Study 10668767 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with SCI who had a history of lower extremity pathologic fracture
Number of subjects: 30
Study 10668767 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with SCI who had no fracture history
Number of subjects: 30
Study 10668767 — intervention group
Group type: COMPARATOR
Intervention: Controls (men without known orthopedic or neurologic impairments)
Number of subjects: 30
Study 9055782 — intervention group
Group type: EXPERIMENTAL
Intervention: Incision and drainage (I&D) of cutaneous abscesses
Number of subjects: 50
Study 8345163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine hydrochloride 20 mg/day
Number of subjects: 21
Study 8345163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3886298 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 mg ibuprofen 4-times daily
Number of subjects: 75
Study 3886298 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg naproxen twice daily
Number of subjects: 75
Study 29061311 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin V 1.6 million units
Number of subjects: 43
Study 29061311 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin 1000mg three times per day for 10 days
Number of subjects: 43
Study 30248105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine (8 mg sustained-release, once daily after breakfast)
Number of subjects: 511
Study 30248105 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched)
Number of subjects: 511
Study 30248105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine
Number of subjects: 511
Study 30248105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study 26537907 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal TME (TaTME)
Number of subjects: 0
Study 26537907 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic TME
Number of subjects: 0
Study 1316259 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (15,000 aXaU) administered 2 hours before surgery (Group A, 19 patients)
Number of subjects: 40
Study 1316259 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (15,000 aXaU) administered 2 hours after surgery (Group B, 21 patients)
Number of subjects: 40
Study 22958237 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vision rehabilitation (LVR) with 2 or 3 therapy sessions (1½ to 2½ hours) and homework to teach effective use of remaining vision and LV devices.
Number of subjects: 330
Study 22958237 — intervention group
Group type: COMPARATOR
Intervention: Basic low vision (LV) with devices dispensed by the optometrist without LV therapy, contact time for dispensing is one hour or less.
Number of subjects: 330
Study 22958237 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vision rehabilitation (LVR)
Number of subjects: 330
Study 22958237 — intervention group
Group type: COMPARATOR
Intervention: Basic low vision (LV)
Number of subjects: 330
Study 20149619 — intervention group
Group type: EXPERIMENTAL
Intervention: LPro (0.50 g protein·kg body weight⁻¹·day⁻¹)
Number of subjects: 22
Study 20149619 — intervention group
Group type: EXPERIMENTAL
Intervention: MPro (0.75 g protein·kg body weight⁻¹·day⁻¹)
Number of subjects: 22
Study 20149619 — intervention group
Group type: EXPERIMENTAL
Intervention: HPro (1.00 g protein·kg body weight⁻¹·day⁻¹)
Number of subjects: 22
Study 20149619 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-by-age interaction
Number of subjects: 22
Study 20149619 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet alone
Number of subjects: 22
Study 18686739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 554
Study 18686739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 554
Study 15917519 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg every 12 h, intravenously or orally)
Number of subjects: 285
Study 15917519 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (1 g every 12 h, intravenously)
Number of subjects: 285
Study 15917519 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 285
Study 15917519 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 285
Study 15917519 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid and Vancomycin
Number of subjects: 285
Study 14733991 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervisory safety‐oriented interaction
Number of subjects: 0
Study 14733991 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention period
Number of subjects: 0
Study 10327426 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (PSI; 0.2 mg/kg)
Number of subjects: 24
Study 10327426 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,4‐methylenedioxyethylamphetamine (MDE; 2 mg/kg)
Number of subjects: 24
Study 10327426 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐methamphetamine (METH; 0.2‐0.4 mg/kg)
Number of subjects: 24
Study 10327426 — intervention group
Group type: COMPARATOR
Intervention: Control (word repetition task)
Number of subjects: 24
Study 8619714 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion (10 mL/kg of whole blood removed before cardiopulmonary bypass)
Number of subjects: 100
Study 8619714 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study 1684515 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 6
Study 1684515 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine
Number of subjects: 6
Study 6744776 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol, 40 to 160 mg/day
Number of subjects: 6
Study 6744776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30940171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy (SSH)
Number of subjects: 424
Study 30940171 — intervention group
Group type: COMPARATOR
Intervention: Modified Manchester operation (MM)
Number of subjects: 424
Study 30940171 — intervention group
Group type: EXPERIMENTAL
Intervention: SSH and MM
Number of subjects: 424
Study 29480035 — intervention group
Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D3/month for 12 months (200,000 IU at baseline)
Number of subjects: 101
Study 29480035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 29480035 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 101
Study 27245666 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal closure during LSH
Number of subjects: 104
Study 27245666 — intervention group
Group type: COMPARATOR
Intervention: Non-closure during LSH
Number of subjects: 104
Study 24716674 — intervention group
Group type: EXPERIMENTAL
Intervention: Video of an expert nurse role model
Number of subjects: 275
Study 24716674 — intervention group
Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 275
Study 22080391 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutridrink®
Number of subjects: 60
Study 22080391 — intervention group
Group type: COMPARATOR
Intervention: Water (placebo)
Number of subjects: 60
Study 20730429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral fascia preservation
Number of subjects: 247
Study 20730429 — intervention group
Group type: COMPARATOR
Intervention: Pectoral fascia removal
Number of subjects: 247
Study 17992396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg/kg, three times at intervals of 36 hours)
Number of subjects: 29
Study 17992396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 17377082 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil anesthesia
Number of subjects: 39
Study 17377082 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 39
Study 17377082 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (propofol-remifentanil and sevoflurane)
Number of subjects: 39
Study 15010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study 10865301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, standardized, 8‐week, in‐hospital cognitive rehabilitation program (n=67)
Number of subjects: 120
Study 10865301 — intervention group
Group type: COMPARATOR
Intervention: Limited home rehabilitation program with weekly telephone support from a psychiatric nurse (n=53)
Number of subjects: 120
Study 9095441 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing videotapes
Number of subjects: 0
Study 9095441 — intervention group
Group type: COMPARATOR
Intervention: Not viewing videotapes
Number of subjects: 0
Study 8232944 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg lamotrigine
Number of subjects: 216
Study 8232944 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg lamotrigine
Number of subjects: 216
Study 8232944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 3725655 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 35
Study 3725655 — intervention group
Group type: COMPARATOR
Intervention: Ticarcillin plus tobramycin
Number of subjects: 35
Study 31750922 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured preventive person-centred consultations with general practitioners (2 sessions)
Number of subjects: 209
Study 31750922 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured preventive consultations
Number of subjects: 209
Study 30901345 — intervention group
Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation (5Hz)
Number of subjects: 0
Study 30901345 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 28628601 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-telementored ultrasound (RTMUS)
Number of subjects: 2
Study 28628601 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-mentored Resuscitative-surgery for torso hemorrhage-control
Number of subjects: 2
Study 28628601 — intervention group
Group type: EXPERIMENTAL
Intervention: Damage Control Surgery (DCS) in weightlessness (0g)
Number of subjects: 2
Study 28628601 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-mentored ultrasound (RTMUS) by an ultrasound-naïve Firefighter
Number of subjects: 2
Study 28628601 — intervention group
Group type: COMPARATOR
Intervention: Remote-mentoring for MedTechs conducting Resuscitative-surgery
Number of subjects: 2
Study 26214076 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-hr abstinence-only intervention
Number of subjects: 509
Study 26214076 — intervention group
Group type: COMPARATOR
Intervention: 8-hr control intervention targeting physical activity and diet
Number of subjects: 509
Study 24182630 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral activation for depression followed by a lifestyle intervention
Number of subjects: 355
Study 24182630 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention with attention control
Number of subjects: 355
Study 21315441 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless implantable haemodynamic monitoring (W-IHM) system
Number of subjects: 550
Study 21315441 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone (control group)
Number of subjects: 550
Study 18982016 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variation in the tenomodulin (TNMD) gene
Number of subjects: 5298
Study 18982016 — intervention group
Group type: EXPERIMENTAL
Intervention: Men from the Finnish Diabetes Prevention Study (DPS)
Number of subjects: 5298
Study 18982016 — intervention group
Group type: COMPARATOR
Intervention: Women
Number of subjects: 5298
Study 16562686 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane‐N2O inhalation anaesthesia with LMA
Number of subjects: 80
Study 16562686 — intervention group
Group type: COMPARATOR
Intervention: Propofol‐ketamine total intravenous anaesthesia (TIVA)
Number of subjects: 80
Study 12973819 — intervention group
Group type: EXPERIMENTAL
Intervention: 500-mg clarithromycin tablet
Number of subjects: 24
Study 12973819 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 24
Study 11121914 — intervention group
Group type: COMPARATOR
Intervention: Ursodeoxycholic acid 500 mg/daily plus placebo (UDCA group, n=44)
Number of subjects: 90
Study 11121914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 500 mg/daily plus colchicine 1 mg/daily (UDCA/C group, n=46)
Number of subjects: 90
Study 11121914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 500 mg/daily plus colchicine 1 mg/daily (UDCA/C group)
Number of subjects: 90
Study 11121914 — intervention group
Group type: COMPARATOR
Intervention: Ursodeoxycholic acid 500 mg/daily plus placebo (UDCA group)
Number of subjects: 90
Study 8941105 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (n = 232)
Number of subjects: 366
Study 8941105 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 134)
Number of subjects: 366
Study 8941105 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 366
Study 1610160 — intervention group
Group type: EXPERIMENTAL
Intervention: Untasted salt tablets (120 mmol/day)
Number of subjects: 9
Study 1610160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2858466 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg/day)
Number of subjects: 11
Study 2858466 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 11
Study 2858466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30768418 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment-Based Family Therapy (ABFT)
Number of subjects: 129
Study 30768418 — intervention group
Group type: COMPARATOR
Intervention: Family-Enhanced Nondirective Supportive Therapy (FE-NST)
Number of subjects: 129
Study 30768418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ABFT and FE-NST
Number of subjects: 129
Study 29636396 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical brain stimulation in the medial temporal lobe (MTL) during verbal memory tasks
Number of subjects: 0
Study 29636396 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical brain stimulation in the medial temporal lobe (MTL) during spatial tasks
Number of subjects: 0
Study 27008286 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidrum guidance (group E)
Number of subjects: 150
Study 27008286 — intervention group
Group type: COMPARATOR
Intervention: LOR technique with a syringe (group C)
Number of subjects: 150
Study 27008286 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 150
Study 24584633 — intervention group
Group type: COMPARATOR
Intervention: Contact heat-evoked potentials (CHEPs) applied to the skin of the leg above the internal malleolus (AIM) with a peak thermal stimulus of 47 °C.
Number of subjects: 60
Study 24584633 — intervention group
Group type: COMPARATOR
Intervention: Contact heat-evoked potentials (CHEPs) applied to the skin of the waist at the anterior superior iliac spine (ASIS) level.
Number of subjects: 60
Study 24584633 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact heat-evoked potentials (CHEPs) applied to the skin of the leg above the internal malleolus (AIM).
Number of subjects: 60
Study 23016888 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoblock appliance
Number of subjects: 16
Study 23016888 — intervention group
Group type: EXPERIMENTAL
Intervention: SILENT NITE (two-piece appliance)
Number of subjects: 16
Study 20124795 — intervention group
Group type: COMPARATOR
Intervention: WT (Progressive Resistance Training)
Number of subjects: 32
Study 20124795 — intervention group
Group type: EXPERIMENTAL
Intervention: WT + ST (Progressive Resistance Training + Static Stretching)
Number of subjects: 32
Study 17402962 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care with supplemental acupressure for eight weeks
Number of subjects: 35
Study 17402962 — intervention group
Group type: COMPARATOR
Intervention: Standard care with supplemental sham acupressure for eight weeks
Number of subjects: 35
Study 17402962 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 35
Study 15321808 — intervention group
Group type: COMPARATOR
Intervention: Met (30 mg methionine/kg body wt)
Number of subjects: 24
Study 15321808 — intervention group
Group type: EXPERIMENTAL
Intervention: MetSer (30 mg methionine + 60.6 mg serine/kg body wt)
Number of subjects: 24
Study 15321808 — intervention group
Group type: EXPERIMENTAL
Intervention: MetCys (30 mg methionine + 12.3 mg cystine/kg body wt)
Number of subjects: 24
Study 15321808 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein (30 mg methionine + 60.6 mg serine + 12.3 mg cystine/kg body wt)
Number of subjects: 24
Study 11958386 — intervention group
Group type: EXPERIMENTAL
Intervention: New progressive treadmill protocol (1.0 mile/h or 1.6 km/h)
Number of subjects: 11
Study 11958386 — intervention group
Group type: COMPARATOR
Intervention: Established protocol (2.0 miles/h or 3.2 km/h)
Number of subjects: 11
Study 9622220 — intervention group
Group type: EXPERIMENTAL
Intervention: 4G/5G genotype in myocardial infarction patients
Number of subjects: 128
Study 9622220 — intervention group
Group type: COMPARATOR
Intervention: 4G/5G genotype in control patients
Number of subjects: 128
Study 9622220 — intervention group
Group type: EXPERIMENTAL
Intervention: Total frequencies of 4G and 5G alleles
Number of subjects: 128
Study 9622220 — intervention group
Group type: EXPERIMENTAL
Intervention: PAI‐1 promoter genotype
Number of subjects: 128
Study 7709864 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in health education message during antenatal sessions
Number of subjects: 0
Study 7709864 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution of sugar-coated chloroquine tablet
Number of subjects: 0
Study 7709864 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention of health education message change and product change
Number of subjects: 0
Study 3315176 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (1.5 mg/m2)
Number of subjects: 120
Study 3315176 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50 mg)
Number of subjects: 120
Study 31451082 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Store Environment Examination (FoodSee) using wearable cameras for 4 days recording images every 7 seconds.
Number of subjects: 168
Study 30110194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg
Number of subjects: 160
Study 30110194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 1 mg/kg plus ipilimumab 3 mg/kg
Number of subjects: 160
Study 30110194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg plus ipilimumab 1 mg/kg
Number of subjects: 160
Study 26641212 — intervention group
Group type: EXPERIMENTAL
Intervention: Total testosterone concentrations
Number of subjects: 508
Study 26641212 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioavailable testosterone
Number of subjects: 508
Study 26641212 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex hormone binding globulin (SHBG)
Number of subjects: 508
Study 25087939 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh group (polypropylene mesh)
Number of subjects: 0
Study 25087939 — intervention group
Group type: COMPARATOR
Intervention: Nonmesh group (standard abdominal wall closure)
Number of subjects: 0
Study 25087939 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh group
Number of subjects: 0
Study 22170363 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D fortified orange juice (350 mg Ca and 100 IU vitamin D per 240 mL serving)
Number of subjects: 171
Study 22170363 — intervention group
Group type: COMPARATOR
Intervention: Control group (unfortified regular or lite orange juice)
Number of subjects: 171
Study 20167141 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry-powder inhaler (MF-DPI), 100 micrograms b.i.d.
Number of subjects: 50
Study 20167141 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry-powder inhaler (MF-DPI), 200 micrograms b.i.d.
Number of subjects: 50
Study 20167141 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry-powder inhaler (MF-DPI), 400 micrograms b.i.d.
Number of subjects: 50
Study 20167141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17345064 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (75 mg/day for 9 days)
Number of subjects: 40
Study 17345064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15711861 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral internal sphincterotomy up to the dentate line
Number of subjects: 0
Study 15711861 — intervention group
Group type: COMPARATOR
Intervention: Lateral internal sphincterotomy up to the fissure apex
Number of subjects: 0
Study 12163878 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health education
Number of subjects: 793
Study 12163878 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 793